NO960586L - Öket tverrbinding av naturlig vev - Google Patents

Öket tverrbinding av naturlig vev

Info

Publication number
NO960586L
NO960586L NO960586A NO960586A NO960586L NO 960586 L NO960586 L NO 960586L NO 960586 A NO960586 A NO 960586A NO 960586 A NO960586 A NO 960586A NO 960586 L NO960586 L NO 960586L
Authority
NO
Norway
Prior art keywords
linking
natural tissue
increased cross
cross
tissue
Prior art date
Application number
NO960586A
Other languages
English (en)
Other versions
NO960586D0 (no
Inventor
William M Mirsch
Thomas L Odland
Kemal Schankereli
Original Assignee
St Jude Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Jude Medical filed Critical St Jude Medical
Publication of NO960586D0 publication Critical patent/NO960586D0/no
Publication of NO960586L publication Critical patent/NO960586L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Materials For Medical Uses (AREA)
  • Confectionery (AREA)

Abstract

Det blir beskrevet behandling av et biologisk vev med en lav konsentrasjon av tverrblndingsmlddel.
NO960586A 1994-06-15 1996-02-14 Öket tverrbinding av naturlig vev NO960586L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25998494A 1994-06-15 1994-06-15
PCT/US1995/007679 WO1995034332A1 (en) 1994-06-15 1995-06-15 Enhanced cross-linking of natural tissues

Publications (2)

Publication Number Publication Date
NO960586D0 NO960586D0 (no) 1996-02-14
NO960586L true NO960586L (no) 1996-03-08

Family

ID=22987319

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960586A NO960586L (no) 1994-06-15 1996-02-14 Öket tverrbinding av naturlig vev

Country Status (9)

Country Link
EP (1) EP0713400A1 (no)
JP (1) JPH09502379A (no)
CN (1) CN1131913A (no)
AU (1) AU2863495A (no)
BR (1) BR9505496A (no)
CA (1) CA2169381C (no)
NO (1) NO960586L (no)
WO (1) WO1995034332A1 (no)
ZA (1) ZA955010B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931969A (en) * 1994-07-29 1999-08-03 Baxter International Inc. Methods and apparatuses for treating biological tissue to mitigate calcification
USRE40570E1 (en) 1994-07-29 2008-11-11 Edwards Lifesciences Corporation Apparatuses and methods for treating biological tissue to mitigate calcification
AUPN363995A0 (en) * 1995-06-19 1995-07-13 Memtec Limited Electrochemical cell
US6316153B1 (en) * 1998-04-21 2001-11-13 The University Of Connecticut Free-form fabricaton using multi-photon excitation
US6214054B1 (en) 1998-09-21 2001-04-10 Edwards Lifesciences Corporation Method for fixation of biological tissues having mitigated propensity for post-implantation calcification and thrombosis and bioprosthetic devices prepared thereby
FR2786400B1 (fr) * 1998-11-30 2002-05-10 Imedex Biomateriaux Procede de preparation d'un materiau collagenique a vitesse de biodegradation in vivo controlee et materiaux obtenus
US20030068815A1 (en) * 1999-02-11 2003-04-10 Stone Kevin R. Sterilized xenograft tissue
AUPR217300A0 (en) * 2000-12-20 2001-01-25 Ketharanathan, Vettivetpillai Method of creating biological and biosynthetic material for implantation
US6812211B2 (en) 2002-03-19 2004-11-02 Michael Andrew Slivka Method for nonsurgical treatment of the intervertebral disc and kit therefor
US7579381B2 (en) 2005-03-25 2009-08-25 Edwards Lifesciences Corporation Treatment of bioprosthetic tissues to mitigate post implantation calcification
US8372437B2 (en) * 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
CN103933612B (zh) 2006-10-27 2016-06-22 爱德华兹生命科学公司 用于外科植入的生物组织
US9101691B2 (en) 2007-06-11 2015-08-11 Edwards Lifesciences Corporation Methods for pre-stressing and capping bioprosthetic tissue
US8357387B2 (en) 2007-12-21 2013-01-22 Edwards Lifesciences Corporation Capping bioprosthetic tissue to reduce calcification
CN101766842B (zh) * 2010-03-22 2013-11-06 四川大学 人工器官用生物组织材料及其制备方法
EP3636293A1 (en) 2010-03-23 2020-04-15 Edwards Lifesciences Corporation Methods of conditioning sheet bioprosthetic tissue
CA2794135C (en) 2010-06-17 2018-01-02 Edwards Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
US8906601B2 (en) 2010-06-17 2014-12-09 Edwardss Lifesciences Corporation Methods for stabilizing a bioprosthetic tissue by chemical modification of antigenic carbohydrates
US9351829B2 (en) 2010-11-17 2016-05-31 Edwards Lifesciences Corporation Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability
US9358107B2 (en) 2011-06-30 2016-06-07 Edwards Lifesciences Corporation Systems, dies, and methods for processing pericardial tissue
US10238771B2 (en) 2012-11-08 2019-03-26 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
US9615922B2 (en) 2013-09-30 2017-04-11 Edwards Lifesciences Corporation Method and apparatus for preparing a contoured biological tissue
US10959839B2 (en) 2013-10-08 2021-03-30 Edwards Lifesciences Corporation Method for directing cellular migration patterns on a biological tissue
US10405975B2 (en) * 2015-10-07 2019-09-10 Boston Scientific Scimed, Inc. Cultured cell leaflet material
US20170173214A1 (en) * 2015-12-21 2017-06-22 Medtronic Vascular, Inc. Methods for preparing dry cross-linked tissue
CA3062547A1 (en) 2017-05-31 2018-12-06 Edwards Lifesciences Corporation Collagen fibers and articles formed therefrom
WO2019147585A1 (en) 2018-01-23 2019-08-01 Edwards Lifesciences Corporation Method for pre-stretching implantable biocompatible materials, and materials and devices produced thereby
WO2020092205A1 (en) 2018-11-01 2020-05-07 Edwards Lifesciences Corporation Transcatheter pulmonic regenerative valve
AU2020399770B2 (en) 2019-12-09 2026-03-12 Edwards Lifesciences Corporation Bioprosthetic tissue preparation
CN111701078B (zh) * 2020-04-20 2022-08-19 上海以心医疗器械有限公司 一种提高生物组织交联度的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405327A (en) * 1982-08-25 1983-09-20 Extracorporeal Medical Specialties, Inc. Method for inhibiting mineralization of natural tissue during implantation
CA1254839A (en) * 1984-08-14 1989-05-30 Mark W. Torrianni Retarded mineralization of implantable tissue by surface active betaines

Also Published As

Publication number Publication date
WO1995034332A1 (en) 1995-12-21
AU2863495A (en) 1996-01-05
ZA955010B (en) 1996-02-08
CA2169381C (en) 2002-01-29
CN1131913A (zh) 1996-09-25
NO960586D0 (no) 1996-02-14
CA2169381A1 (en) 1995-12-21
JPH09502379A (ja) 1997-03-11
EP0713400A1 (en) 1996-05-29
BR9505496A (pt) 1997-08-12

Similar Documents

Publication Publication Date Title
FI973163A7 (fi) Pidätyskyvyttömyyden hoitaminen käyttämällä (S)-oksibutyniiniä ja (S)- desetyylioksibutyniiniä
ATE104380T1 (de) Sauerstoffdelignifizierung und enzymatische behandlung.
NO960586D0 (no) Öket tverrbinding av naturlig vev
NO890496D0 (no) Fremgangsmaate og anordning for ikke-inntrengende akustisk undersoekelse av elastisiteten til mykt, biologisk vev.
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
ES536547A0 (es) Un conjugado de una molecula biologicamente activa
NO891896D0 (no) Fremgangsmaate og innretning for behandling av medisinsk spesialavfall.
ATE269740T1 (de) Einführungsvorrichtungssystem für den rechten vorhof
FI921232A7 (fi) Siilorehun entsyymaattinen käsittely
DE69838338D1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DE69500089D1 (de) Behandlung von Geflügel
DE69412552D1 (de) Medizinisches Instrument zur Behandlung von Sinusitis
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69527749D1 (de) Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE69603635D1 (de) Katheterstruktur für medizinische Behandlung
DE59605959D1 (de) Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
DE3381624D1 (de) Mittel zur behandlung von wunden.
DE69619051D1 (de) Behandlung von Füllstoffen mit Oxasilacycloalkanen
ATE81455T1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
ES2094757T3 (es) Un factor megacariocitopoyetico.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DE69522685D1 (de) Behandlung von blut-plasma